These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9239450)

  • 1. Possible involvement of ATP-dependent K-channel related mechanisms in the antihypertensive and cough suppressant effects of the novel ACE inhibitor (2S, 3aS, 7aS)-1-(N2-nicotinoyl-L-lysyl-gamma-D-glutamyl)octahydro-1H- indole-2-carboxylic acid.
    Nagata S; Takeyama K; Hosoki K; Karasawa T
    Arzneimittelforschung; 1997 Jun; 47(6):726-30. PubMed ID: 9239450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive properties of a new long-acting angiotensin converting enzyme inhibitor in renin-dependent and independent hypertensive models.
    Nagata S; Takeyama K; Fukuya F; Nagai R; Hosoki K; Nishimura K; Deguchi T; Karasawa T
    Arzneimittelforschung; 1995 Aug; 45(8):853-8. PubMed ID: 7575746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antitussive effect of cromakalim in rats is not associated with adenosine triphosphate sensitive K+ channels.
    Kamei J; Iwamoto Y; Narita M; Suzuki T; Misawa M; Kasuya Y
    Res Commun Chem Pathol Pharmacol; 1993 May; 80(2):201-10. PubMed ID: 8391711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent.
    Katz LB; Giardino EC; Salata JJ; Moore JB; Falotico R
    J Pharmacol Exp Ther; 1993 Nov; 267(2):648-56. PubMed ID: 8246137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the relaxing effects of cicletanine and cromakalim on vascular smooth muscle.
    Deitmer P; Golenhofen K; Noack T
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):35-42. PubMed ID: 1383629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide.
    Quast U; Cook NS
    J Pharmacol Exp Ther; 1989 Jul; 250(1):261-71. PubMed ID: 2501478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [ACE inhibitors with SH groups have no effect of ATP-dependent K channels--a dissertation].
    Köppel H; Gasser R; Klein W; Holzmann S
    Acta Med Austriaca; 1996; 23(3):109-12. PubMed ID: 8967287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Y-27152, a long-acting K+ channel opener with less tachycardia: antihypertensive effects in hypertensive rats and dogs in conscious state.
    Nakajima T; Shinohara T; Yaoka O; Fukunari A; Shinagawa K; Aoki K; Katoh A; Yamanaka T; Setoguchi M; Tahara T
    J Pharmacol Exp Ther; 1992 May; 261(2):730-6. PubMed ID: 1578381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CI-906 and CI-907: new orally active nonsulfhydryl angiotensin-converting enzyme inhibitors.
    Kaplan HR; Cohen DM; Essenburg AD; Major TC; Mertz TE; Ryan MJ
    Fed Proc; 1984 Apr; 43(5):1326-9. PubMed ID: 6323223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of BTS 67 582, a novel antidiabetic agent, in normal and diabetic rats.
    Jones RB; Dickinson K; Anthony DM; Marita AR; Kaul CL; Buckett WR
    Br J Pharmacol; 1997 Mar; 120(6):1135-43. PubMed ID: 9134227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RP 49356 and cromakalim relax airway smooth muscle in vitro by opening a sulphonylurea-sensitive K+ channel: a comparison with nifedipine.
    Raeburn D; Brown TJ
    J Pharmacol Exp Ther; 1991 Feb; 256(2):480-5. PubMed ID: 1899701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. General pharmacology of the novel angiotensin converting enzyme inhibitor alacepril. 1st communication: Effects on cardiovascular, visceral and renal functions and on blood.
    Matsuno Y; Taira N; Fujitani B; Ito T; Kadokawa T
    Arzneimittelforschung; 1986; 36(1):55-62. PubMed ID: 3513777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metamizol acts as an ATP sensitive potassium channel opener to inhibit the contracting response induced by angiotensin II but not to norepinephrine in rat thoracic aorta smooth muscle.
    Valenzuela F; García-Saisó S; Lemini C; Ramírez-Solares R; Vidrio H; Mendoza-Fernández V
    Vascul Pharmacol; 2005 Aug; 43(2):120-7. PubMed ID: 15958287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypotensive and hemodynamic effects of the new non-sulfhydryl angiotensin converting enzyme inhibitor N-[8-amino-1(S)-carboxyoctyl]-L-alanyl-L-proline.
    Shirota M; Iijima M; Ushijima T; Kajiwara Y; Kitabatake K
    Arzneimittelforschung; 1990 Dec; 40(12):1303-9. PubMed ID: 2095126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic profiles of YM934, a novel potassium channel opener.
    Uchida W; Masuda N; Taguchi T; Shibasaki K; Shirai Y; Asano M; Matsumoto Y; Tsuzuki R; Fujikura T; Takenaka T
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):180-7. PubMed ID: 7511745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasorelaxant effects of cromakalim in rats are mediated by glibenclamide-sensitive potassium channels.
    Cavero I; Mondot S; Mestre M
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1261-8. PubMed ID: 2495353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Action of KC-399, a newly synthesized potassium channel opener, on mechanical activity and 86Rb efflux in rat aorta.
    Tamura K; Suzuki Y; Yoshida S; Nabata H
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):220-6. PubMed ID: 7511750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive effects of CI-907 (indolapril): a novel nonsulfhydryl angiotensin converting enzyme inhibitor.
    Ryan MJ; Boucher DM; Cohen DM; Essenburg AD; Major TC; Mertz TE; Olszewski BJ; Randolph AE; Singer RM; Kaplan HR
    J Pharmacol Exp Ther; 1984 Feb; 228(2):312-8. PubMed ID: 6319675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological and toxicological studies of the new angiotensin converting enzyme inhibitor moexipril hydrochloride.
    Friehe H; Ney P
    Arzneimittelforschung; 1997 Feb; 47(2):132-44. PubMed ID: 9079232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of JTV-506, a new K+ channel activator, on airway smooth muscle contraction and systemic blood pressure.
    Ando T; Kume H; Urata Y; Takagi K
    Clin Exp Allergy; 1997 Jun; 27(6):705-13. PubMed ID: 9208193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.